Emergent BioSolutions Inc (EBS)
8.30
+0.15
(+1.84%)
USD |
NYSE |
Dec 24, 16:00
Emergent BioSolutions Cash from Investing (Quarterly): 112.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -594.00M |
| Tonix Pharmaceuticals Holding Corp | -0.009M |
| Chimerix Inc | 28.32M |
| Geron Corp | -0.554M |
| MAIA Biotechnology Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 153.70M |
| Cash from Financing (Quarterly) | -180.30M |
| Free Cash Flow | 138.10M |
| Free Cash Flow Per Share (Quarterly) | 2.660 |
| Free Cash Flow to Equity (Quarterly) | 347.50M |
| Free Cash Flow to Firm (Quarterly) | 154.59M |
| Free Cash Flow Yield | 31.32% |